CHUGAI PHARMACEUTICAL CO., LTD. (4519)

Market cap
¥14.02T
P/E ratio
34.2x
Chugai Pharmaceutical develops and sells prescription medicines in Japan and internationally, with research operations spanning the US, Europe, and Asia.
Period EndEarnings per share (JPY)YoY (%)
Dec 31, 2025263.7+12.04%
Dec 31, 2024235.4+18.99%
Dec 31, 2023197.8-13.10%
Dec 31, 2022227.6+23.52%
Dec 31, 2021184.3+41.05%
Dec 31, 2020130.7-54.61%
Dec 31, 2019287.8+70.24%
Dec 31, 2018169.1+27.09%
Dec 31, 2017133+35.59%
Dec 31, 201698.1-12.39%
Dec 31, 2015112+19.75%
Dec 31, 201493.5+0.06%
Dec 31, 201393.5+5.52%
Dec 31, 201288.6+36.80%
Dec 31, 201164.8
AI Chat